How do patients and other members of the public engage with the orphan drug development? a narrative qualitative synthesis

HIGHLIGHTS

• who: Julia Frost from the We included , published papers from a , year period (2012-2022)-with studies originating from the USA have published the Article: How do patients and other members of the public engage with the orphan drug development? A narrative qualitative synthesis, in the Journal: (JOURNAL) of June/10,/2021
• what: The aim of this paper is to review qualitative literature about how patients and other members of the public engage with orphan drug development. The aim of the new Clinical Trials Regulation is to harmonise the processes for assessment and supervision of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.